Rapt Therapeutics, Inc. (RAPT)
57.69
+0.01
(+0.02%)
USD |
NASDAQ |
Feb 06, 16:00
57.66
-0.03
(-0.05%)
After-Hours: 20:00
Rapt Therapeutics SG&A Expense (TTM) : 29.76M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Penumbra, Inc. | 630.26M |
| Boston Scientific Corp. | 6.888B |
| Johnson & Johnson | 23.68B |
| Merck & Co., Inc. | 10.73B |
| Pfizer Inc. | 13.79B |